Global Custom Antibody Service Market
Global Custom Antibody Service Market

Custom Antibody Service Comprehensive Study by Type (Antibody Development, Antigen Preparation, Immunisation & Hybridoma Production, Antibody Characterisation, Antibody Production & Purification, Antibody Fragmentation & Labelling), Source (Mice, Rabbit, Other), End users (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organisations), Custom antibody type (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Others), Research Area (Oncology, Infectious Diseases, Immunology, Neurobiology, Stem Cell, Cardiovascular Diseases, Others) Players and Region - Global Market Outlook to 2025

Custom Antibody Service Market Segmented into XX Submarkets. | Forecast Years: 2020- 2025  

Jun 2020 Edition 250 Pages 213 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Scope of the Study

Custom Antibody Services provides highly specific, and high-quality products, which are designed just for the individuals, which enables to develop innovative solutions to advance scientific discovery. It includes competitively priced packages and purification options for antibody production. These are supported by online tools for peptide design and project tracking. The custom antibody service provide support for all types and steps of antibody production like peptide design, synthesis, and carrier protein conjugation, animal immunisation, serum collection, or hybridoma fusion, titer analysis, and final antibody purification.

The market study is being classified by Type (Antibody Development, Antigen Preparation, Immunisation & Hybridoma Production, Antibody Characterisation, Antibody Production & Purification and Antibody Fragmentation & Labelling) and major geographies with country level break-up.

Thermo Fisher Scientific Inc. (United States), Bio-Rad Laboratories, Inc. (United States), Merck Group (Germany), Abcam plc (United Kingdom), Cell Signaling Technology, Inc. (United States), Agilent Technologies, Inc. (United States), GenScript (United States), BioLegend, Inc. (United States), Rockland Immunochemicals (United States) and ProMab Biotechnologies (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Innovagen AB (Sweden) and ProteoGenix (United States).

The companies are now exploring the market by adopting mergers & acquisitions, expansions, investments, new developments in existing products and collaborations as their preferred strategies. The players are also exploring new geographies and industries through expansions and acquisitions so as to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Custom Antibody Service market throughout the predicted period.

Segment Analysis
AdvanceMarketAnalytics has segmented the market of Global Custom Antibody Service market by Type, Application and Region.

On the basis of geography, the market of Custom Antibody Service has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increasing Research Activities in life Sciences Industry
  • Rising Industry Academia Collaboration

Market Trend
  • Increasing Research Activities in the Field of mAb-based Therapeutics

Restraints
  • High Expenses Involved in the Production of Antibodies

Opportunities
  • Expansion in Antibody Therapeutics Pipeline
  • Increasing Quality Concerns over Catalog Antibodies

Challenges
  • High Competition due to the Presence of Major Player


In 2018, Abcam launched the (PBS)-only recombinant antibodies and the new anti-PD-L1 antibody clone MKP1A07310 (clone 73-10) which is developed in collaboration with Merck KGaA


Key Target Audience
Custom antibody service provider, Manufacturers, Government associations, Research organisations, Enterprise software vendors and Others

Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Antibody Development
  • Antigen Preparation
  • Immunisation & Hybridoma Production
  • Antibody Characterisation
  • Antibody Production & Purification
  • Antibody Fragmentation & Labelling
By Source
  • Mice
  • Rabbit
  • Other

By End users
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organisations

By Custom antibody type
  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant Antibodies
  • Others

By Research Area
  • Oncology
  • Infectious Diseases
  • Immunology
  • Neurobiology
  • Stem Cell
  • Cardiovascular Diseases
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Research Activities in life Sciences Industry
      • 3.2.2. Rising Industry Academia Collaboration
    • 3.3. Market Challenges
      • 3.3.1. High Competition due to the Presence of Major Player
    • 3.4. Market Trends
      • 3.4.1. Increasing Research Activities in the Field of mAb-based Therapeutics
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Custom Antibody Service, by Type, Source , End users, Custom antibody type , Research Area and Region (value) (2014-2019)
    • 5.1. Introduction
    • 5.2. Global Custom Antibody Service (Value)
      • 5.2.1. Global Custom Antibody Service by: Type (Value)
        • 5.2.1.1. Antibody Development
        • 5.2.1.2. Antigen Preparation
        • 5.2.1.3. Immunisation & Hybridoma Production
        • 5.2.1.4. Antibody Characterisation
        • 5.2.1.5. Antibody Production & Purification
        • 5.2.1.6. Antibody Fragmentation & Labelling
      • 5.2.2. Global Custom Antibody Service by: End users (Value)
        • 5.2.2.1. Pharmaceutical & Biotechnology Companies
        • 5.2.2.2. Academic & Research Institutes
        • 5.2.2.3. Contract Research Organisations
      • 5.2.3. Global Custom Antibody Service Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Custom Antibody Service: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2019)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Bio-Rad Laboratories, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Merck Group (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Abcam plc (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Cell Signaling Technology, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Agilent Technologies, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. GenScript (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. BioLegend, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Rockland Immunochemicals (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. ProMab Biotechnologies (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Custom Antibody Service Sale, by Type, Source , End users, Custom antibody type , Research Area and Region (value) (2020-2025)
    • 7.1. Introduction
    • 7.2. Global Custom Antibody Service (Value)
      • 7.2.1. Global Custom Antibody Service by: Type (Value)
        • 7.2.1.1. Antibody Development
        • 7.2.1.2. Antigen Preparation
        • 7.2.1.3. Immunisation & Hybridoma Production
        • 7.2.1.4. Antibody Characterisation
        • 7.2.1.5. Antibody Production & Purification
        • 7.2.1.6. Antibody Fragmentation & Labelling
      • 7.2.2. Global Custom Antibody Service by: End users (Value)
        • 7.2.2.1. Pharmaceutical & Biotechnology Companies
        • 7.2.2.2. Academic & Research Institutes
        • 7.2.2.3. Contract Research Organisations
      • 7.2.3. Global Custom Antibody Service Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Custom Antibody Service: by Type(USD Million)
  • Table 2. Custom Antibody Service Antibody Development , by Region USD Million (2014-2019)
  • Table 3. Custom Antibody Service Antigen Preparation , by Region USD Million (2014-2019)
  • Table 4. Custom Antibody Service Immunisation & Hybridoma Production , by Region USD Million (2014-2019)
  • Table 5. Custom Antibody Service Antibody Characterisation , by Region USD Million (2014-2019)
  • Table 6. Custom Antibody Service Antibody Production & Purification , by Region USD Million (2014-2019)
  • Table 7. Custom Antibody Service Antibody Fragmentation & Labelling , by Region USD Million (2014-2019)
  • Table 8. Custom Antibody Service: by End users(USD Million)
  • Table 9. Custom Antibody Service Pharmaceutical & Biotechnology Companies , by Region USD Million (2014-2019)
  • Table 10. Custom Antibody Service Academic & Research Institutes , by Region USD Million (2014-2019)
  • Table 11. Custom Antibody Service Contract Research Organisations , by Region USD Million (2014-2019)
  • Table 12. South America Custom Antibody Service, by Country USD Million (2014-2019)
  • Table 13. South America Custom Antibody Service, by Type USD Million (2014-2019)
  • Table 14. South America Custom Antibody Service, by Source USD Million (2014-2019)
  • Table 15. South America Custom Antibody Service, by End users USD Million (2014-2019)
  • Table 16. South America Custom Antibody Service, by Custom antibody type USD Million (2014-2019)
  • Table 17. South America Custom Antibody Service, by Research Area USD Million (2014-2019)
  • Table 18. Brazil Custom Antibody Service, by Type USD Million (2014-2019)
  • Table 19. Brazil Custom Antibody Service, by Source USD Million (2014-2019)
  • Table 20. Brazil Custom Antibody Service, by End users USD Million (2014-2019)
  • Table 21. Brazil Custom Antibody Service, by Custom antibody type USD Million (2014-2019)
  • Table 22. Brazil Custom Antibody Service, by Research Area USD Million (2014-2019)
  • Table 23. Argentina Custom Antibody Service, by Type USD Million (2014-2019)
  • Table 24. Argentina Custom Antibody Service, by Source USD Million (2014-2019)
  • Table 25. Argentina Custom Antibody Service, by End users USD Million (2014-2019)
  • Table 26. Argentina Custom Antibody Service, by Custom antibody type USD Million (2014-2019)
  • Table 27. Argentina Custom Antibody Service, by Research Area USD Million (2014-2019)
  • Table 28. Rest of South America Custom Antibody Service, by Type USD Million (2014-2019)
  • Table 29. Rest of South America Custom Antibody Service, by Source USD Million (2014-2019)
  • Table 30. Rest of South America Custom Antibody Service, by End users USD Million (2014-2019)
  • Table 31. Rest of South America Custom Antibody Service, by Custom antibody type USD Million (2014-2019)
  • Table 32. Rest of South America Custom Antibody Service, by Research Area USD Million (2014-2019)
  • Table 33. Asia Pacific Custom Antibody Service, by Country USD Million (2014-2019)
  • Table 34. Asia Pacific Custom Antibody Service, by Type USD Million (2014-2019)
  • Table 35. Asia Pacific Custom Antibody Service, by Source USD Million (2014-2019)
  • Table 36. Asia Pacific Custom Antibody Service, by End users USD Million (2014-2019)
  • Table 37. Asia Pacific Custom Antibody Service, by Custom antibody type USD Million (2014-2019)
  • Table 38. Asia Pacific Custom Antibody Service, by Research Area USD Million (2014-2019)
  • Table 39. China Custom Antibody Service, by Type USD Million (2014-2019)
  • Table 40. China Custom Antibody Service, by Source USD Million (2014-2019)
  • Table 41. China Custom Antibody Service, by End users USD Million (2014-2019)
  • Table 42. China Custom Antibody Service, by Custom antibody type USD Million (2014-2019)
  • Table 43. China Custom Antibody Service, by Research Area USD Million (2014-2019)
  • Table 44. Japan Custom Antibody Service, by Type USD Million (2014-2019)
  • Table 45. Japan Custom Antibody Service, by Source USD Million (2014-2019)
  • Table 46. Japan Custom Antibody Service, by End users USD Million (2014-2019)
  • Table 47. Japan Custom Antibody Service, by Custom antibody type USD Million (2014-2019)
  • Table 48. Japan Custom Antibody Service, by Research Area USD Million (2014-2019)
  • Table 49. India Custom Antibody Service, by Type USD Million (2014-2019)
  • Table 50. India Custom Antibody Service, by Source USD Million (2014-2019)
  • Table 51. India Custom Antibody Service, by End users USD Million (2014-2019)
  • Table 52. India Custom Antibody Service, by Custom antibody type USD Million (2014-2019)
  • Table 53. India Custom Antibody Service, by Research Area USD Million (2014-2019)
  • Table 54. South Korea Custom Antibody Service, by Type USD Million (2014-2019)
  • Table 55. South Korea Custom Antibody Service, by Source USD Million (2014-2019)
  • Table 56. South Korea Custom Antibody Service, by End users USD Million (2014-2019)
  • Table 57. South Korea Custom Antibody Service, by Custom antibody type USD Million (2014-2019)
  • Table 58. South Korea Custom Antibody Service, by Research Area USD Million (2014-2019)
  • Table 59. Taiwan Custom Antibody Service, by Type USD Million (2014-2019)
  • Table 60. Taiwan Custom Antibody Service, by Source USD Million (2014-2019)
  • Table 61. Taiwan Custom Antibody Service, by End users USD Million (2014-2019)
  • Table 62. Taiwan Custom Antibody Service, by Custom antibody type USD Million (2014-2019)
  • Table 63. Taiwan Custom Antibody Service, by Research Area USD Million (2014-2019)
  • Table 64. Australia Custom Antibody Service, by Type USD Million (2014-2019)
  • Table 65. Australia Custom Antibody Service, by Source USD Million (2014-2019)
  • Table 66. Australia Custom Antibody Service, by End users USD Million (2014-2019)
  • Table 67. Australia Custom Antibody Service, by Custom antibody type USD Million (2014-2019)
  • Table 68. Australia Custom Antibody Service, by Research Area USD Million (2014-2019)
  • Table 69. Rest of Asia-Pacific Custom Antibody Service, by Type USD Million (2014-2019)
  • Table 70. Rest of Asia-Pacific Custom Antibody Service, by Source USD Million (2014-2019)
  • Table 71. Rest of Asia-Pacific Custom Antibody Service, by End users USD Million (2014-2019)
  • Table 72. Rest of Asia-Pacific Custom Antibody Service, by Custom antibody type USD Million (2014-2019)
  • Table 73. Rest of Asia-Pacific Custom Antibody Service, by Research Area USD Million (2014-2019)
  • Table 74. Europe Custom Antibody Service, by Country USD Million (2014-2019)
  • Table 75. Europe Custom Antibody Service, by Type USD Million (2014-2019)
  • Table 76. Europe Custom Antibody Service, by Source USD Million (2014-2019)
  • Table 77. Europe Custom Antibody Service, by End users USD Million (2014-2019)
  • Table 78. Europe Custom Antibody Service, by Custom antibody type USD Million (2014-2019)
  • Table 79. Europe Custom Antibody Service, by Research Area USD Million (2014-2019)
  • Table 80. Germany Custom Antibody Service, by Type USD Million (2014-2019)
  • Table 81. Germany Custom Antibody Service, by Source USD Million (2014-2019)
  • Table 82. Germany Custom Antibody Service, by End users USD Million (2014-2019)
  • Table 83. Germany Custom Antibody Service, by Custom antibody type USD Million (2014-2019)
  • Table 84. Germany Custom Antibody Service, by Research Area USD Million (2014-2019)
  • Table 85. France Custom Antibody Service, by Type USD Million (2014-2019)
  • Table 86. France Custom Antibody Service, by Source USD Million (2014-2019)
  • Table 87. France Custom Antibody Service, by End users USD Million (2014-2019)
  • Table 88. France Custom Antibody Service, by Custom antibody type USD Million (2014-2019)
  • Table 89. France Custom Antibody Service, by Research Area USD Million (2014-2019)
  • Table 90. Italy Custom Antibody Service, by Type USD Million (2014-2019)
  • Table 91. Italy Custom Antibody Service, by Source USD Million (2014-2019)
  • Table 92. Italy Custom Antibody Service, by End users USD Million (2014-2019)
  • Table 93. Italy Custom Antibody Service, by Custom antibody type USD Million (2014-2019)
  • Table 94. Italy Custom Antibody Service, by Research Area USD Million (2014-2019)
  • Table 95. United Kingdom Custom Antibody Service, by Type USD Million (2014-2019)
  • Table 96. United Kingdom Custom Antibody Service, by Source USD Million (2014-2019)
  • Table 97. United Kingdom Custom Antibody Service, by End users USD Million (2014-2019)
  • Table 98. United Kingdom Custom Antibody Service, by Custom antibody type USD Million (2014-2019)
  • Table 99. United Kingdom Custom Antibody Service, by Research Area USD Million (2014-2019)
  • Table 100. Netherlands Custom Antibody Service, by Type USD Million (2014-2019)
  • Table 101. Netherlands Custom Antibody Service, by Source USD Million (2014-2019)
  • Table 102. Netherlands Custom Antibody Service, by End users USD Million (2014-2019)
  • Table 103. Netherlands Custom Antibody Service, by Custom antibody type USD Million (2014-2019)
  • Table 104. Netherlands Custom Antibody Service, by Research Area USD Million (2014-2019)
  • Table 105. Rest of Europe Custom Antibody Service, by Type USD Million (2014-2019)
  • Table 106. Rest of Europe Custom Antibody Service, by Source USD Million (2014-2019)
  • Table 107. Rest of Europe Custom Antibody Service, by End users USD Million (2014-2019)
  • Table 108. Rest of Europe Custom Antibody Service, by Custom antibody type USD Million (2014-2019)
  • Table 109. Rest of Europe Custom Antibody Service, by Research Area USD Million (2014-2019)
  • Table 110. MEA Custom Antibody Service, by Country USD Million (2014-2019)
  • Table 111. MEA Custom Antibody Service, by Type USD Million (2014-2019)
  • Table 112. MEA Custom Antibody Service, by Source USD Million (2014-2019)
  • Table 113. MEA Custom Antibody Service, by End users USD Million (2014-2019)
  • Table 114. MEA Custom Antibody Service, by Custom antibody type USD Million (2014-2019)
  • Table 115. MEA Custom Antibody Service, by Research Area USD Million (2014-2019)
  • Table 116. Middle East Custom Antibody Service, by Type USD Million (2014-2019)
  • Table 117. Middle East Custom Antibody Service, by Source USD Million (2014-2019)
  • Table 118. Middle East Custom Antibody Service, by End users USD Million (2014-2019)
  • Table 119. Middle East Custom Antibody Service, by Custom antibody type USD Million (2014-2019)
  • Table 120. Middle East Custom Antibody Service, by Research Area USD Million (2014-2019)
  • Table 121. Africa Custom Antibody Service, by Type USD Million (2014-2019)
  • Table 122. Africa Custom Antibody Service, by Source USD Million (2014-2019)
  • Table 123. Africa Custom Antibody Service, by End users USD Million (2014-2019)
  • Table 124. Africa Custom Antibody Service, by Custom antibody type USD Million (2014-2019)
  • Table 125. Africa Custom Antibody Service, by Research Area USD Million (2014-2019)
  • Table 126. North America Custom Antibody Service, by Country USD Million (2014-2019)
  • Table 127. North America Custom Antibody Service, by Type USD Million (2014-2019)
  • Table 128. North America Custom Antibody Service, by Source USD Million (2014-2019)
  • Table 129. North America Custom Antibody Service, by End users USD Million (2014-2019)
  • Table 130. North America Custom Antibody Service, by Custom antibody type USD Million (2014-2019)
  • Table 131. North America Custom Antibody Service, by Research Area USD Million (2014-2019)
  • Table 132. United States Custom Antibody Service, by Type USD Million (2014-2019)
  • Table 133. United States Custom Antibody Service, by Source USD Million (2014-2019)
  • Table 134. United States Custom Antibody Service, by End users USD Million (2014-2019)
  • Table 135. United States Custom Antibody Service, by Custom antibody type USD Million (2014-2019)
  • Table 136. United States Custom Antibody Service, by Research Area USD Million (2014-2019)
  • Table 137. Canada Custom Antibody Service, by Type USD Million (2014-2019)
  • Table 138. Canada Custom Antibody Service, by Source USD Million (2014-2019)
  • Table 139. Canada Custom Antibody Service, by End users USD Million (2014-2019)
  • Table 140. Canada Custom Antibody Service, by Custom antibody type USD Million (2014-2019)
  • Table 141. Canada Custom Antibody Service, by Research Area USD Million (2014-2019)
  • Table 142. Mexico Custom Antibody Service, by Type USD Million (2014-2019)
  • Table 143. Mexico Custom Antibody Service, by Source USD Million (2014-2019)
  • Table 144. Mexico Custom Antibody Service, by End users USD Million (2014-2019)
  • Table 145. Mexico Custom Antibody Service, by Custom antibody type USD Million (2014-2019)
  • Table 146. Mexico Custom Antibody Service, by Research Area USD Million (2014-2019)
  • Table 147. Company Basic Information, Sales Area and Its Competitors
  • Table 148. Company Basic Information, Sales Area and Its Competitors
  • Table 149. Company Basic Information, Sales Area and Its Competitors
  • Table 150. Company Basic Information, Sales Area and Its Competitors
  • Table 151. Company Basic Information, Sales Area and Its Competitors
  • Table 152. Company Basic Information, Sales Area and Its Competitors
  • Table 153. Company Basic Information, Sales Area and Its Competitors
  • Table 154. Company Basic Information, Sales Area and Its Competitors
  • Table 155. Company Basic Information, Sales Area and Its Competitors
  • Table 156. Company Basic Information, Sales Area and Its Competitors
  • Table 157. Custom Antibody Service: by Type(USD Million)
  • Table 158. Custom Antibody Service Antibody Development , by Region USD Million (2020-2025)
  • Table 159. Custom Antibody Service Antigen Preparation , by Region USD Million (2020-2025)
  • Table 160. Custom Antibody Service Immunisation & Hybridoma Production , by Region USD Million (2020-2025)
  • Table 161. Custom Antibody Service Antibody Characterisation , by Region USD Million (2020-2025)
  • Table 162. Custom Antibody Service Antibody Production & Purification , by Region USD Million (2020-2025)
  • Table 163. Custom Antibody Service Antibody Fragmentation & Labelling , by Region USD Million (2020-2025)
  • Table 164. Custom Antibody Service: by End users(USD Million)
  • Table 165. Custom Antibody Service Pharmaceutical & Biotechnology Companies , by Region USD Million (2020-2025)
  • Table 166. Custom Antibody Service Academic & Research Institutes , by Region USD Million (2020-2025)
  • Table 167. Custom Antibody Service Contract Research Organisations , by Region USD Million (2020-2025)
  • Table 168. South America Custom Antibody Service, by Country USD Million (2020-2025)
  • Table 169. South America Custom Antibody Service, by Type USD Million (2020-2025)
  • Table 170. South America Custom Antibody Service, by Source USD Million (2020-2025)
  • Table 171. South America Custom Antibody Service, by End users USD Million (2020-2025)
  • Table 172. South America Custom Antibody Service, by Custom antibody type USD Million (2020-2025)
  • Table 173. South America Custom Antibody Service, by Research Area USD Million (2020-2025)
  • Table 174. Brazil Custom Antibody Service, by Type USD Million (2020-2025)
  • Table 175. Brazil Custom Antibody Service, by Source USD Million (2020-2025)
  • Table 176. Brazil Custom Antibody Service, by End users USD Million (2020-2025)
  • Table 177. Brazil Custom Antibody Service, by Custom antibody type USD Million (2020-2025)
  • Table 178. Brazil Custom Antibody Service, by Research Area USD Million (2020-2025)
  • Table 179. Argentina Custom Antibody Service, by Type USD Million (2020-2025)
  • Table 180. Argentina Custom Antibody Service, by Source USD Million (2020-2025)
  • Table 181. Argentina Custom Antibody Service, by End users USD Million (2020-2025)
  • Table 182. Argentina Custom Antibody Service, by Custom antibody type USD Million (2020-2025)
  • Table 183. Argentina Custom Antibody Service, by Research Area USD Million (2020-2025)
  • Table 184. Rest of South America Custom Antibody Service, by Type USD Million (2020-2025)
  • Table 185. Rest of South America Custom Antibody Service, by Source USD Million (2020-2025)
  • Table 186. Rest of South America Custom Antibody Service, by End users USD Million (2020-2025)
  • Table 187. Rest of South America Custom Antibody Service, by Custom antibody type USD Million (2020-2025)
  • Table 188. Rest of South America Custom Antibody Service, by Research Area USD Million (2020-2025)
  • Table 189. Asia Pacific Custom Antibody Service, by Country USD Million (2020-2025)
  • Table 190. Asia Pacific Custom Antibody Service, by Type USD Million (2020-2025)
  • Table 191. Asia Pacific Custom Antibody Service, by Source USD Million (2020-2025)
  • Table 192. Asia Pacific Custom Antibody Service, by End users USD Million (2020-2025)
  • Table 193. Asia Pacific Custom Antibody Service, by Custom antibody type USD Million (2020-2025)
  • Table 194. Asia Pacific Custom Antibody Service, by Research Area USD Million (2020-2025)
  • Table 195. China Custom Antibody Service, by Type USD Million (2020-2025)
  • Table 196. China Custom Antibody Service, by Source USD Million (2020-2025)
  • Table 197. China Custom Antibody Service, by End users USD Million (2020-2025)
  • Table 198. China Custom Antibody Service, by Custom antibody type USD Million (2020-2025)
  • Table 199. China Custom Antibody Service, by Research Area USD Million (2020-2025)
  • Table 200. Japan Custom Antibody Service, by Type USD Million (2020-2025)
  • Table 201. Japan Custom Antibody Service, by Source USD Million (2020-2025)
  • Table 202. Japan Custom Antibody Service, by End users USD Million (2020-2025)
  • Table 203. Japan Custom Antibody Service, by Custom antibody type USD Million (2020-2025)
  • Table 204. Japan Custom Antibody Service, by Research Area USD Million (2020-2025)
  • Table 205. India Custom Antibody Service, by Type USD Million (2020-2025)
  • Table 206. India Custom Antibody Service, by Source USD Million (2020-2025)
  • Table 207. India Custom Antibody Service, by End users USD Million (2020-2025)
  • Table 208. India Custom Antibody Service, by Custom antibody type USD Million (2020-2025)
  • Table 209. India Custom Antibody Service, by Research Area USD Million (2020-2025)
  • Table 210. South Korea Custom Antibody Service, by Type USD Million (2020-2025)
  • Table 211. South Korea Custom Antibody Service, by Source USD Million (2020-2025)
  • Table 212. South Korea Custom Antibody Service, by End users USD Million (2020-2025)
  • Table 213. South Korea Custom Antibody Service, by Custom antibody type USD Million (2020-2025)
  • Table 214. South Korea Custom Antibody Service, by Research Area USD Million (2020-2025)
  • Table 215. Taiwan Custom Antibody Service, by Type USD Million (2020-2025)
  • Table 216. Taiwan Custom Antibody Service, by Source USD Million (2020-2025)
  • Table 217. Taiwan Custom Antibody Service, by End users USD Million (2020-2025)
  • Table 218. Taiwan Custom Antibody Service, by Custom antibody type USD Million (2020-2025)
  • Table 219. Taiwan Custom Antibody Service, by Research Area USD Million (2020-2025)
  • Table 220. Australia Custom Antibody Service, by Type USD Million (2020-2025)
  • Table 221. Australia Custom Antibody Service, by Source USD Million (2020-2025)
  • Table 222. Australia Custom Antibody Service, by End users USD Million (2020-2025)
  • Table 223. Australia Custom Antibody Service, by Custom antibody type USD Million (2020-2025)
  • Table 224. Australia Custom Antibody Service, by Research Area USD Million (2020-2025)
  • Table 225. Rest of Asia-Pacific Custom Antibody Service, by Type USD Million (2020-2025)
  • Table 226. Rest of Asia-Pacific Custom Antibody Service, by Source USD Million (2020-2025)
  • Table 227. Rest of Asia-Pacific Custom Antibody Service, by End users USD Million (2020-2025)
  • Table 228. Rest of Asia-Pacific Custom Antibody Service, by Custom antibody type USD Million (2020-2025)
  • Table 229. Rest of Asia-Pacific Custom Antibody Service, by Research Area USD Million (2020-2025)
  • Table 230. Europe Custom Antibody Service, by Country USD Million (2020-2025)
  • Table 231. Europe Custom Antibody Service, by Type USD Million (2020-2025)
  • Table 232. Europe Custom Antibody Service, by Source USD Million (2020-2025)
  • Table 233. Europe Custom Antibody Service, by End users USD Million (2020-2025)
  • Table 234. Europe Custom Antibody Service, by Custom antibody type USD Million (2020-2025)
  • Table 235. Europe Custom Antibody Service, by Research Area USD Million (2020-2025)
  • Table 236. Germany Custom Antibody Service, by Type USD Million (2020-2025)
  • Table 237. Germany Custom Antibody Service, by Source USD Million (2020-2025)
  • Table 238. Germany Custom Antibody Service, by End users USD Million (2020-2025)
  • Table 239. Germany Custom Antibody Service, by Custom antibody type USD Million (2020-2025)
  • Table 240. Germany Custom Antibody Service, by Research Area USD Million (2020-2025)
  • Table 241. France Custom Antibody Service, by Type USD Million (2020-2025)
  • Table 242. France Custom Antibody Service, by Source USD Million (2020-2025)
  • Table 243. France Custom Antibody Service, by End users USD Million (2020-2025)
  • Table 244. France Custom Antibody Service, by Custom antibody type USD Million (2020-2025)
  • Table 245. France Custom Antibody Service, by Research Area USD Million (2020-2025)
  • Table 246. Italy Custom Antibody Service, by Type USD Million (2020-2025)
  • Table 247. Italy Custom Antibody Service, by Source USD Million (2020-2025)
  • Table 248. Italy Custom Antibody Service, by End users USD Million (2020-2025)
  • Table 249. Italy Custom Antibody Service, by Custom antibody type USD Million (2020-2025)
  • Table 250. Italy Custom Antibody Service, by Research Area USD Million (2020-2025)
  • Table 251. United Kingdom Custom Antibody Service, by Type USD Million (2020-2025)
  • Table 252. United Kingdom Custom Antibody Service, by Source USD Million (2020-2025)
  • Table 253. United Kingdom Custom Antibody Service, by End users USD Million (2020-2025)
  • Table 254. United Kingdom Custom Antibody Service, by Custom antibody type USD Million (2020-2025)
  • Table 255. United Kingdom Custom Antibody Service, by Research Area USD Million (2020-2025)
  • Table 256. Netherlands Custom Antibody Service, by Type USD Million (2020-2025)
  • Table 257. Netherlands Custom Antibody Service, by Source USD Million (2020-2025)
  • Table 258. Netherlands Custom Antibody Service, by End users USD Million (2020-2025)
  • Table 259. Netherlands Custom Antibody Service, by Custom antibody type USD Million (2020-2025)
  • Table 260. Netherlands Custom Antibody Service, by Research Area USD Million (2020-2025)
  • Table 261. Rest of Europe Custom Antibody Service, by Type USD Million (2020-2025)
  • Table 262. Rest of Europe Custom Antibody Service, by Source USD Million (2020-2025)
  • Table 263. Rest of Europe Custom Antibody Service, by End users USD Million (2020-2025)
  • Table 264. Rest of Europe Custom Antibody Service, by Custom antibody type USD Million (2020-2025)
  • Table 265. Rest of Europe Custom Antibody Service, by Research Area USD Million (2020-2025)
  • Table 266. MEA Custom Antibody Service, by Country USD Million (2020-2025)
  • Table 267. MEA Custom Antibody Service, by Type USD Million (2020-2025)
  • Table 268. MEA Custom Antibody Service, by Source USD Million (2020-2025)
  • Table 269. MEA Custom Antibody Service, by End users USD Million (2020-2025)
  • Table 270. MEA Custom Antibody Service, by Custom antibody type USD Million (2020-2025)
  • Table 271. MEA Custom Antibody Service, by Research Area USD Million (2020-2025)
  • Table 272. Middle East Custom Antibody Service, by Type USD Million (2020-2025)
  • Table 273. Middle East Custom Antibody Service, by Source USD Million (2020-2025)
  • Table 274. Middle East Custom Antibody Service, by End users USD Million (2020-2025)
  • Table 275. Middle East Custom Antibody Service, by Custom antibody type USD Million (2020-2025)
  • Table 276. Middle East Custom Antibody Service, by Research Area USD Million (2020-2025)
  • Table 277. Africa Custom Antibody Service, by Type USD Million (2020-2025)
  • Table 278. Africa Custom Antibody Service, by Source USD Million (2020-2025)
  • Table 279. Africa Custom Antibody Service, by End users USD Million (2020-2025)
  • Table 280. Africa Custom Antibody Service, by Custom antibody type USD Million (2020-2025)
  • Table 281. Africa Custom Antibody Service, by Research Area USD Million (2020-2025)
  • Table 282. North America Custom Antibody Service, by Country USD Million (2020-2025)
  • Table 283. North America Custom Antibody Service, by Type USD Million (2020-2025)
  • Table 284. North America Custom Antibody Service, by Source USD Million (2020-2025)
  • Table 285. North America Custom Antibody Service, by End users USD Million (2020-2025)
  • Table 286. North America Custom Antibody Service, by Custom antibody type USD Million (2020-2025)
  • Table 287. North America Custom Antibody Service, by Research Area USD Million (2020-2025)
  • Table 288. United States Custom Antibody Service, by Type USD Million (2020-2025)
  • Table 289. United States Custom Antibody Service, by Source USD Million (2020-2025)
  • Table 290. United States Custom Antibody Service, by End users USD Million (2020-2025)
  • Table 291. United States Custom Antibody Service, by Custom antibody type USD Million (2020-2025)
  • Table 292. United States Custom Antibody Service, by Research Area USD Million (2020-2025)
  • Table 293. Canada Custom Antibody Service, by Type USD Million (2020-2025)
  • Table 294. Canada Custom Antibody Service, by Source USD Million (2020-2025)
  • Table 295. Canada Custom Antibody Service, by End users USD Million (2020-2025)
  • Table 296. Canada Custom Antibody Service, by Custom antibody type USD Million (2020-2025)
  • Table 297. Canada Custom Antibody Service, by Research Area USD Million (2020-2025)
  • Table 298. Mexico Custom Antibody Service, by Type USD Million (2020-2025)
  • Table 299. Mexico Custom Antibody Service, by Source USD Million (2020-2025)
  • Table 300. Mexico Custom Antibody Service, by End users USD Million (2020-2025)
  • Table 301. Mexico Custom Antibody Service, by Custom antibody type USD Million (2020-2025)
  • Table 302. Mexico Custom Antibody Service, by Research Area USD Million (2020-2025)
  • Table 303. Research Programs/Design for This Report
  • Table 304. Key Data Information from Secondary Sources
  • Table 305. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Custom Antibody Service: by Type USD Million (2014-2019)
  • Figure 5. Global Custom Antibody Service: by End users USD Million (2014-2019)
  • Figure 6. South America Custom Antibody Service Share (%), by Country
  • Figure 7. Asia Pacific Custom Antibody Service Share (%), by Country
  • Figure 8. Europe Custom Antibody Service Share (%), by Country
  • Figure 9. MEA Custom Antibody Service Share (%), by Country
  • Figure 10. North America Custom Antibody Service Share (%), by Country
  • Figure 11. Global Custom Antibody Service share by Players 2019 (%)
  • Figure 12. Global Custom Antibody Service share by Players (Top 3) 2019(%)
  • Figure 13. Global Custom Antibody Service share by Players (Top 5) 2019(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Thermo Fisher Scientific Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 16. Thermo Fisher Scientific Inc. (United States) Revenue: by Geography 2019
  • Figure 17. Bio-Rad Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Bio-Rad Laboratories, Inc. (United States) Revenue: by Geography 2019
  • Figure 19. Merck Group (Germany) Revenue, Net Income and Gross profit
  • Figure 20. Merck Group (Germany) Revenue: by Geography 2019
  • Figure 21. Abcam plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 22. Abcam plc (United Kingdom) Revenue: by Geography 2019
  • Figure 23. Cell Signaling Technology, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Cell Signaling Technology, Inc. (United States) Revenue: by Geography 2019
  • Figure 25. Agilent Technologies, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Agilent Technologies, Inc. (United States) Revenue: by Geography 2019
  • Figure 27. GenScript (United States) Revenue, Net Income and Gross profit
  • Figure 28. GenScript (United States) Revenue: by Geography 2019
  • Figure 29. BioLegend, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. BioLegend, Inc. (United States) Revenue: by Geography 2019
  • Figure 31. Rockland Immunochemicals (United States) Revenue, Net Income and Gross profit
  • Figure 32. Rockland Immunochemicals (United States) Revenue: by Geography 2019
  • Figure 33. ProMab Biotechnologies (United States) Revenue, Net Income and Gross profit
  • Figure 34. ProMab Biotechnologies (United States) Revenue: by Geography 2019
  • Figure 35. Global Custom Antibody Service: by Type USD Million (2020-2025)
  • Figure 36. Global Custom Antibody Service: by End users USD Million (2020-2025)
  • Figure 37. South America Custom Antibody Service Share (%), by Country
  • Figure 38. Asia Pacific Custom Antibody Service Share (%), by Country
  • Figure 39. Europe Custom Antibody Service Share (%), by Country
  • Figure 40. MEA Custom Antibody Service Share (%), by Country
  • Figure 41. North America Custom Antibody Service Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Thermo Fisher Scientific Inc. (United States)
  • Bio-Rad Laboratories, Inc. (United States)
  • Merck Group (Germany)
  • Abcam plc (United Kingdom)
  • Cell Signaling Technology, Inc. (United States)
  • Agilent Technologies, Inc. (United States)
  • GenScript (United States)
  • BioLegend, Inc. (United States)
  • Rockland Immunochemicals (United States)
  • ProMab Biotechnologies (United States)
Additional players considered in the study are as follows:
Innovagen AB (Sweden) , ProteoGenix (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation